Cole Pinnow

CIK: 0002024135

Transaction Breakdown

Open Market Buys (P)1 (20.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (60.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (20.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

COGT

Cogent Biosciences, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

COGT
Cogent Biosciences, Inc.
Dec 17, 2025
Award(A)
Direct
50K shares-
COGT
Cogent Biosciences, Inc.
Dec 17, 2025
Award(A)
Direct
214K shares-
COGT
Cogent Biosciences, Inc.
Dec 17, 2025
Tax Payment(F)
Direct
94.8K shares at avg. $39.45$3.7M
COGT
Cogent Biosciences, Inc.
Jan 23, 2025
Award(A)
Stock Option (Right to Buy)
Direct
240K shares-
COGT
Cogent Biosciences, Inc.
Jan 14, 2025
Purchase(P)
Direct
43.8K shares at avg. $7.60$332K

		Type	Shares	Price		Ownership
Dec 17, 2025	COGT Cogent Biosciences, Inc.	Award(A)	50,000	-	-	Direct
Dec 17, 2025	COGT Cogent Biosciences, Inc.	Award(A)	214,000	-	-	Direct
Dec 17, 2025	COGT Cogent Biosciences, Inc.	Tax Payment(F)	94,800	$39.45	$3,739,860	Direct
Jan 23, 2025	COGT Cogent Biosciences, Inc.	Award(A) Stock Option (Right to Buy)	240,000	-	-	Direct
Jan 14, 2025	COGT Cogent Biosciences, Inc.	Purchase(P)	43,750	$7.60	$332,413	Direct

1-5 of 5 transactions

About Pinnow Cole

Pinnow Cole (SEC CIK 0002024135) files insider reports with the SEC as Chief Commercial Officer of Cogent Biosciences, Inc. (COGT).

Signal8 holds 3 ownership filings by Pinnow Cole, all Form 4s, filed between Jan 15, 2025 and Dec 19, 2025. Those filings report 5 transactions, from Jan 14, 2025 to Dec 17, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Pinnow Cole's filings is in WALTHAM, MA.

Recent filings by Pinnow Cole

Dec 17, 2025: Grants or awards of COGT shares (2 lines, Form 4, code A).
Dec 17, 2025: Tax withholding of COGT shares (Form 4, code F).
Jan 23, 2025: Grant or award of COGT derivative securities (Form 4, code A).
Jan 14, 2025: Open-market purchase of COGT shares (Form 4, code P).

Other insiders filing for Cogent Biosciences, Inc. (COGT)

Ferrante Karen Jean, Director
Harwin Peter Evan, Director
CAIN CHRISTOPHER W., Director
Shegog Todd, Director
Morris Arlene, Director
Ros Matthew, Director

How to read Form 4 transaction codes